recent
studi
demonstr
therapi
target
innat
immun
system
potenti
provid
transient
nonspecif
protect
varieti
infecti
organ
howev
potenti
enhanc
efficaci
treatment
use
nanoscal
deliveri
platform
requir
depth
evalu
employ
nanolipoprotein
nlp
platform
enhanc
efficaci
innat
immun
agonist
demonstr
synthet
tolllik
receptor
tlr
agonist
monophosphoryl
lipid
mpla
cpg
oligodeoxynucleotid
cpg
readili
incorpor
nlp
conjug
mpla
cpg
nlp
mpla
nlp
cpg
nlp
respect
significantli
enhanc
immunostimulatori
profil
vitro
vivo
compar
administr
agonist
alon
evidenc
signific
increas
cytokin
product
cell
surfac
express
activ
marker
upregul
immunoregulatori
gene
importantli
enhanc
cytokin
product
agonist
conjug
nlp
also
observ
primari
human
dendrit
cell
furthermor
balbc
mice
pretreat
cpg
nlp
construct
surviv
lethal
influenza
challeng
wherea
pretreat
cpg
alon
effect
surviv
select
class
pathogen
organ
pose
signific
threat
public
health
due
high
level
morbid
mortal
induc
low
infecti
dose
eas
transmiss
aerosol
mani
organ
efficaci
therapi
avail
optim
event
bioterror
attack
acut
diseas
emerg
vaccin
long
consid
gold
standard
medic
countermeasur
diseas
prevent
may
avail
suitabl
widespread
administr
gener
public
due
safeti
concern
similarli
antimicrobi
compound
may
insuffici
counter
wide
rang
unknown
deliber
alter
drugresist
pathogen
potenti
lead
resist
develop
innov
approach
allow
rapid
respons
tradit
emerg
pathogen
paramount
recent
target
innat
immun
system
counter
infect
gain
attent
therapeut
strategi
innat
immun
system
evolv
millennia
function
immedi
nonspecif
upon
encount
pathogen
thu
modul
singl
innat
host
resist
mechan
potenti
offer
broadspectrum
efficaci
independ
pathogen
ident
furthermor
therapeut
target
innat
immun
would
less
like
promot
develop
resist
pathogen
directli
target
past
fifteen
year
pattern
recognit
receptor
prr
tolllik
receptor
tlr
emerg
intric
innat
immun
surveil
system
evolv
detect
varieti
invad
pathogen
express
socal
pathogenassoci
molecular
pattern
pamp
tlr
play
key
role
earli
step
immun
respons
infect
robust
tlr
activ
critic
downstream
induct
sustain
adapt
immun
respons
pathogen
clearanc
importantli
welldescrib
associ
tlr
myriad
infect
underscor
import
therapeut
target
current
research
effort
focus
clinic
translat
understand
tlr
innat
immun
vaccin
adjuv
perhap
extens
explor
applic
tlr
agonist
although
recent
effort
explor
use
tlr
monotherapi
enhanc
host
resist
infect
varieti
pathogen
howev
signific
limit
effect
tlr
agonist
standalon
therapeut
includ
margin
shortliv
protect
thu
limit
util
preand
postexposur
scenario
furthermor
dose
requir
afford
protect
sever
studi
significantli
higher
dose
typic
coadminist
combin
subunit
antigen
vaccin
applic
potenti
rais
toxic
concern
henc
strategi
improv
therapeut
index
tlr
agonist
vivo
urgent
need
nanoparticl
wide
explor
deliveri
vehicl
immunotherapeut
applic
primarili
improv
vaccin
immunogen
reduc
toxic
associ
high
dose
adjuv
improv
pharmacokinet
profil
enhanc
stabil
labil
vaccin
compon
although
function
indic
ultim
heighten
adapt
immun
respons
nanoparticlemedi
enhanc
vaccin
immunogen
like
due
least
part
heighten
innat
immun
respons
inde
sever
recent
studi
demonstr
prostimulatori
effect
divers
nanoparticl
innat
immun
respons
vitro
vivo
studi
aim
util
nanolipoprotein
particl
nlp
improv
efficaci
innat
immun
target
therapeut
nlp
discoid
nanometers
particl
compris
selfassembl
phospholipid
membran
apolipoprotein
previous
describ
nlp
flexibl
vaccin
platform
coloc
administr
protein
antigen
synthet
tlr
agonist
monophosphoryl
lipid
mpla
cpg
oligodeoxynucleotid
cpg
immun
antigen
agonist
nlp
complex
contain
either
influenza
hemagglutinin
yersinia
pesti
lcrv
antigen
cpg
mpla
result
significantli
higher
antibodi
titer
mice
antigen
versu
coadministr
antigen
agonist
without
nlp
conjug
thu
nlp
demonstr
effect
compat
platform
immun
modul
strategi
use
previous
vivo
applic
support
broad
util
investig
interact
nlp
complex
innat
immun
system
mice
human
method
develop
incorpor
quantif
mpla
cpg
within
nlp
investig
impact
nlp
conjug
innat
immun
respons
mpla
cpg
measur
cytokin
secret
express
immunoregulatori
gene
surfac
express
level
key
activ
marker
antigen
present
cell
apc
stimul
cytokin
product
also
investig
primari
human
dendrit
cell
final
employ
mous
model
influenza
order
test
efficaci
cpg
nlp
construct
amelior
infect
nilipid
synthet
mpla
purchas
avanti
polar
lipid
inc
alabast
al
cholesterolmodifi
cpg
oligonucleotid
purchas
custom
order
biosearch
technolog
novato
ca
mous
experi
done
util
follow
sequenc
class
b
cpg
e
phosphorothio
linkag
experi
done
human
cell
util
follow
sequenc
class
cpg
g
g
g
gacgacgtcgtgg
g
g
g
g
e
denot
phosphorothio
linkag
worth
note
cholesterol
modifi
cpg
compound
refer
cpg
express
clone
produc
ntermin
kda
fragment
apolipoprotein
thioredoxintag
fusion
construct
kindli
provid
dr
karl
weisgrab
express
purifi
use
similar
protocol
previous
describ
endotoxin
contamin
remov
revers
phase
highperform
liquid
chromatographi
hplc
load
onto
vydac
column
mm
mm
grace
davidson
deerfield
il
elut
wateracetonitril
gradient
tfa
mlmin
fraction
contain
lyophil
resuspend
pyrogenfre
water
aliquot
store
c
mpla
nlp
cpg
nlp
assembl
describ
previous
briefli
mpla
nlp
assembl
appropri
amount
chloroformsolubil
nilipid
mol
dopc
mol
mpla
mol
determin
prior
experi
ad
glass
reaction
vial
chloroform
remov
use
stream
n
agit
form
thin
lipid
film
lipid
solubil
pb
buffer
mm
nacl
mm
kcl
mm
na
hpo
mm
kh
po
use
mm
sodium
cholat
ad
solubil
lipid
suspens
final
lipid
ratio
typic
mm
use
final
assembl
volum
cpg
nlp
assembl
lipid
constitu
prepar
describ
cpg
hydrat
lyophil
state
use
pyrogenfre
water
ad
solubil
lipid
togeth
assembl
dialyz
overnight
pb
remov
cholat
filter
mm
spin
filter
remov
larg
particul
matter
sampl
subsequ
analyz
purifi
size
exclus
chromatographi
sec
superdex
pg
hiload
column
ge
healthcar
piscataway
nj
pb
buffer
mlmin
flow
rate
concentr
nlp
sampl
determin
use
advanc
protein
assay
reagent
cytoskeleton
inc
denver
co
use
bsa
standard
free
mpla
prepar
first
solubil
mpla
powder
form
dmso
concentr
mgml
solut
dilut
mgml
water
sonic
tip
sonic
branson
sonif
model
branson
ultrason
danburi
ct
highest
power
suspens
reach
clariti
buffer
eppendorf
tube
vial
use
assembl
process
endotoxinfre
worth
noth
lipid
contain
nickel
chelat
head
group
nilipid
includ
nlp
assembl
reaction
nlp
gener
studi
requir
ni
function
group
want
ensur
result
obtain
studi
would
applic
ongo
nlpbase
vaccin
studi
protein
antigen
attach
via
nihi
tag
interact
addit
longterm
object
approach
describ
herein
examin
effect
multipl
immun
modul
singl
nlp
thu
nilipid
includ
order
evalu
nlp
equip
attach
histag
adjuv
histag
flagellin
incorpor
mpla
nlp
assess
revers
phase
hplc
modifi
publish
procedur
briefli
ml
concentr
nlp
stock
contain
mpla
speedvacuum
dri
lipophil
compon
extract
dri
pellet
extract
buffer
meoh
chcl
h
constant
agit
centrifug
pellet
insolubl
materi
solvent
transfer
glass
inject
vial
hplc
analysi
shimadzu
precis
hplc
system
mpla
standard
prepar
extract
buffer
mgml
sampl
standard
analyz
luna
column
mm
mm
phenomenex
torrenc
ca
use
constant
flow
rate
mlmin
c
gradient
condit
buffer
methanol
water
tfa
buffer
b
isopropanol
tfa
follow
min
b
min
b
min
b
min
b
min
b
min
b
mpla
detect
use
evapor
light
scatter
detector
elsd
c
gain
sampl
concentr
calcul
use
quadrat
curv
fit
calibr
standard
r
use
shimadzu
labsolut
softwar
typic
assembl
mass
ratio
mpla
ca
incorpor
cpg
nlp
quantifi
use
quantit
oligreen
dye
invitrogen
carlsbad
ca
wide
use
quantifi
ssdna
briefli
standard
cpg
solut
mgml
prepar
dilut
te
buffer
mm
trisehcl
mm
edta
ph
cpg
nlp
sampl
also
dilut
te
buffer
ml
sampl
cpg
standard
ad
plate
duplic
follow
addit
ml
aqueou
work
solut
quantit
oligreen
reagent
fluoresc
sampl
measur
excit
emiss
wavelength
nm
nm
respect
sinc
standard
tradit
ssdna
cpg
contain
phosphorothiol
back
bone
standard
curv
sigmoid
rather
linear
therefor
standard
curv
establish
fit
standard
sigmoid
function
use
calcul
cpg
concentr
cpg
nlp
worth
note
fluoresc
valu
within
slope
region
sigmoid
function
use
calcul
cpg
concentr
sinc
valu
satur
region
prone
error
ensur
nlp
affect
fluoresc
emiss
quantit
oligreen
dye
fluoresc
valu
free
cpg
standard
cpg
standard
presenc
nlp
compar
signific
differ
observ
number
cpg
molecul
per
nlp
calcul
use
experiment
determin
protein
concentr
assum
nlp
contain
protein
typic
assembl
mass
ratio
cpg
ca
quantif
endotoxin
level
conduct
use
endosaf
charl
river
charleston
sc
endotoxin
test
system
base
limulu
amebocyt
lysat
lal
assay
purifi
contain
less
eumg
protein
final
nlp
prepar
contain
eumg
base
content
vivo
vitro
experi
use
ex
vivo
isol
mous
cell
influenza
challeng
experi
perform
lawrenc
livermor
nation
laboratori
phsassur
facil
accord
guidelin
set
anim
care
use
committe
balbc
male
mice
week
obtain
harlan
laboratori
livermor
ca
influenza
infect
experi
perform
univers
rochest
femal
balbc
e
mice
purchas
nation
cancer
institutefrederick
frederick
md
mice
maintain
specif
pathogenfre
facil
univers
rochest
accord
institut
guidelin
infect
week
age
cell
maintain
dulbecco
modifi
eagl
media
dmem
invitrogen
supplement
heat
inactiv
fetal
bovin
serum
fb
invitrogen
penicillinstreptomycin
mix
invitrogen
c
thioglycol
elicit
primari
periton
macrophag
pmp
isol
previous
describ
briefli
male
balbc
mice
inject
intraperiton
ip
ml
wv
brewer
thioglycol
broth
five
day
post
inject
mice
euthan
periton
macrophag
isol
periton
lavag
isol
macrophag
allow
adher
tissu
cultur
plate
rpmi
invitrogen
fb
penicillinstreptomycin
mix
overnight
c
nonadher
cell
wash
adher
cell
place
experiment
condit
vitro
assay
unless
otherwis
note
cell
incub
nlp
optimem
media
invitrogen
ad
supplement
protein
label
alexa
fluor
dye
aminereact
succinimidyl
ester
invitrogen
incub
assembl
nlp
nlp
dye
molar
ratio
least
h
reaction
perform
pb
buffer
contain
mm
sodium
bicarbon
ph
complet
reaction
mm
tri
ph
ad
incub
min
quench
unreact
dye
sampl
run
sec
superdex
pc
column
mlmin
ge
healthcar
piscataway
nj
purifi
label
nlp
unreact
dye
nlp
cpg
nlp
mpla
nlp
incub
cell
h
c
subsequ
analyz
flow
cytometri
flow
cytometri
perform
use
facscalibur
bd
bioscienc
data
analyz
use
flowjo
version
softwar
tree
star
intracellular
local
experi
cell
incub
nm
lysotrack
red
invitrogen
mitotrack
red
invitrogen
h
c
incub
cell
rins
time
fresh
media
cell
incub
label
nlp
construct
h
c
bright
field
fluoresc
imag
dual
label
cell
acquir
use
axiovert
microscop
zeiss
minneapoli
mn
multipl
channel
mode
equip
photometr
coolsnap
hq
ccd
camera
photometr
tucson
az
label
nlp
imag
use
nm
excit
filter
nm
emiss
filter
lysotrack
mitotrack
dye
imag
use
e
excit
filter
emiss
filter
imag
analyz
process
use
axiovis
rel
softwar
serum
cytokin
level
assess
h
postip
inject
indic
concentr
nlp
cpg
nlp
mpla
nlp
free
mpla
free
cpg
pb
vehicl
control
captur
elisa
perform
quantifi
tnfa
rant
product
tnfa
rant
quantifi
use
duoset
kit
r
system
accord
manufactur
instruct
quantifi
use
purifiedbiotinyl
antibodi
pair
clone
bd
bioscienc
elisa
detect
use
streptavidinhrp
bd
bioscienc
sureblu
reserv
tmb
e
tetramethylbenzidin
substrat
kpl
inc
gaithersburg
md
nlp
equival
dose
mg
mpla
nlp
complex
ca
mg
cpg
nlp
cpg
mg
mpla
nlp
mpla
mg
pb
inject
ip
mice
per
group
spleen
collect
min
h
postinject
immedi
place
rnalat
stabil
solut
qiagen
preserv
rna
integr
rna
subsequ
purifi
stabil
spleen
use
rneasi
microarray
tissu
mini
kit
qiagen
rna
two
spleen
pool
mg
order
gener
two
cdna
sampl
per
experiment
condit
use
rt
first
strand
synthesi
kit
qiagen
accord
manufactur
instruct
realtim
quantit
rtpcr
analysi
sampl
carri
use
mous
antibacteri
respons
pcr
array
sabiosci
abi
prism
sequenc
detector
appli
biosystem
express
level
target
gene
report
averag
fold
chang
calcul
independ
array
compar
express
level
pb
control
spleen
data
analyz
use
sabiosci
onlin
analysi
softwar
avail
http
pcrdataanalysissabiosciencescompcrarrayanalysi
php
biolegend
min
ice
ml
per
sampl
bd
bioscienc
ad
min
prior
sampl
acquisit
dead
cell
exclus
flow
cytometri
perform
use
facscalibur
data
analyz
use
flowjo
softwar
vivo
analysi
cpg
uptak
nlp
assembl
cpg
modifi
includ
cholesterol
moieti
end
quasar
molecul
end
custom
order
biosearch
technolog
novato
ca
mice
inject
ip
mg
cpgquasar
nlp
free
cpgquasar
spleen
harvest
indic
time
point
singl
cell
suspens
splenocyt
obtain
stain
flow
cytometr
analysi
describ
cell
per
stain
incub
ml
pb
fb
fc
block
prior
sampl
acquisit
dead
cell
exclus
cell
popul
defin
macrophag
convent
dendrit
cell
cdc
plasmacytoid
dendrit
cell
pdc
flow
cytometri
perform
use
facscalibur
data
analyz
use
flowjo
softwar
ex
vivo
analysi
singl
cell
suspens
splenocty
purifi
popul
use
mac
bead
miltenyi
biotech
sort
accord
manufactur
instruct
purifi
cell
incub
mgml
cpgquasar
nlp
cpgquasar
plate
h
analyz
cpgquasar
uptak
flow
cytometri
flow
cytometri
perform
use
facscalibur
data
analyz
use
flowjo
softwar
intracellular
cytokin
express
assess
use
method
similar
previous
describ
whole
blood
collect
healthi
human
donor
bd
bioscienc
intern
donor
program
peripher
blood
mononuclear
cell
pmbc
isol
blood
use
bd
vacutain
cell
prepar
tube
bd
bioscienc
cell
activ
indic
concentr
cpg
nlp
mpla
nlp
cpg
mpla
rpmi
fb
c
h
brefeldin
bd
bioscienc
ad
final
concentr
mgml
cell
incub
addit
h
c
cell
treat
mm
edta
min
room
temperatur
place
c
water
bath
overnight
cell
surfac
marker
detect
antibodi
bd
bioscienc
cell
incub
min
room
temperatur
follow
antibodi
lin
use
recommend
concentr
cell
fix
permeabil
use
bd
cytofixcytoperm
solut
bd
bioscienc
min
room
temperatur
cell
incub
follow
antibodi
intracellular
protein
detect
ifnap
hladr
recommend
concentr
sampl
acquir
use
bd
facscanto
bd
bioscienc
data
analyz
use
flowjo
softwar
mpla
cpg
incorpor
nlp
outlin
fig
gener
mpla
nlp
cpg
nlp
respect
assess
incorpor
mpla
nlp
platform
mpla
ad
assembl
reaction
mpla
nlp
molar
ratio
vari
incorpor
nlp
monitor
hplc
use
evapor
light
scatter
detector
hplc
chromatogram
mpla
peak
increas
mpla
nlp
ratio
shown
fig
expect
increas
mpla
peak
intens
observ
increas
mpla
nlp
ratio
howev
increas
linear
indic
higher
ratio
signific
proport
mpla
ad
assembl
incorpor
nlp
quantifi
effect
final
mpla
nlp
ratio
purifi
mpla
nlp
construct
plot
function
increas
cpg
incorpor
ratio
decreas
nlp
peak
elut
time
r
min
r
min
observ
coupl
increas
peak
absorb
intens
characterist
success
cpg
incorpor
unincorpor
cpg
observ
highest
cpg
ratio
tr
f
analysi
cpg
incorpor
nlp
increas
initi
cpgtonlp
ratio
strong
correl
input
final
cpgtonlp
ratio
observ
cpg
molecul
per
nlp
higher
cpg
ratio
signific
amount
cpg
incorpor
nlp
cpg
quantifi
use
quantit
oligreen
ssdna
quantif
reagent
initi
mpla
nlp
ratio
use
assembl
reaction
mpla
nlp
input
fig
experiment
valu
close
follow
theoret
plot
ie
mpla
reaction
incorpor
nlp
mole
ratio
higher
ratio
actual
incorpor
valu
deviat
theoret
valu
indic
decreas
effici
mpla
incorpor
higher
ratio
thu
subsequ
experi
nlp
assembl
mpla
nlp
molar
ratio
similar
titrat
assembl
reaction
perform
cpg
incorpor
evalu
size
exclus
chromatographi
sec
fig
nlp
assembl
cpg
nlp
molar
ratio
rang
sinc
cpg
retent
time
r
min
significantli
smaller
nlp
r
min
unincorpor
cpg
readili
resolv
nlp
sec
sec
analysi
decreas
nlp
r
shift
min
min
increas
peak
intens
observ
indic
cpg
incorpor
shift
retent
time
expect
sinc
incorpor
mani
larger
compound
nlp
includ
cpg
increas
overal
stoke
diamet
nlp
addit
increas
absorb
nm
expect
cpg
incorpor
due
inher
absorb
cpg
nm
therefor
two
trend
indic
success
incorpor
cpg
cpg
nlp
ratio
higher
peak
correspond
unincorpor
cpg
observ
r
min
addit
cpg
nlp
construct
quantit
measur
incorpor
effici
cpg
nlp
purifi
sec
cpg
nlp
ratio
secpurifi
construct
plot
function
initi
cpg
nlp
ratio
use
assembl
reaction
cpg
nlp
input
fig
base
analysi
incorpor
cpg
assembl
particl
track
close
theoret
valu
ratio
approxim
ie
cpg
ad
assembl
incorpor
nlp
trend
deviat
substanti
theoret
valu
ratio
higher
littl
addit
cpg
incorpor
nlp
cpg
nlp
input
ratio
thu
maxim
cpg
incorpor
nlp
minim
loss
unincorpor
cpg
cpg
nlp
assembl
cpg
nlp
ratio
subsequ
experi
combin
result
demonstr
success
incorpor
cpg
mpla
nlp
accur
quantit
cpg
mpla
concentr
evalu
interact
nlp
immun
cell
first
assess
abil
mous
macrophag
intern
nlp
complex
nlp
mpla
nlp
cpg
nlp
fluoresc
label
concentr
mgml
base
scaffold
protein
concentr
incub
mous
cell
primari
periton
macrophag
pmp
h
uptak
particl
quantifi
flow
cytometri
nlp
construct
rapidli
intern
cell
top
panel
pmp
bottom
panel
posit
fluoresc
fig
rapid
intern
nlp
cargo
depend
sinc
construct
intern
similarli
mpla
cpg
interact
cellsurfac
endosom
tlr
respect
next
assess
subcellular
local
nlp
upon
intern
cell
pretreat
lysotrack
dye
h
prior
addit
nlp
analyz
h
later
confoc
microscopi
nlp
coloc
lysotrack
dye
indic
particl
traffick
lysosom
fig
similar
experi
perform
use
mitotrack
dye
coloc
nlp
mitotrack
observ
mitochondria
data
shown
taken
togeth
result
demonstr
nlp
construct
rapidli
intern
mous
macrophag
traffick
lysosom
degrad
next
investig
abil
nlp
construct
activ
mous
macrophag
vitro
cpg
nlp
mpla
nlp
compar
free
cpg
mpla
variou
concentr
abil
elicit
cytokin
secret
cell
control
empti
nlp
without
conjug
agonist
includ
equival
dose
estim
base
scaffold
protein
concentr
cpg
nlp
mpla
nlp
construct
cpg
nlp
mpla
nlp
construct
elicit
higher
level
tnfa
rant
compar
equival
dose
free
cpg
mpla
fig
b
order
assess
whether
cpg
nlp
mpla
nlp
elicit
similar
pattern
enhanc
cytokin
secret
relev
vitro
model
pmp
stimul
nlp
cpg
nlp
mpla
nlp
free
cpg
free
mpla
similar
observ
cell
conjug
cpg
mpla
nlp
significantli
enhanc
immunostimulatori
abil
compar
equival
dose
free
cpg
free
mpla
fig
interestingli
empti
nlp
elicit
low
level
tnfa
rant
cell
dosedepend
fashion
small
detect
level
rant
pmp
fig
taken
togeth
data
demonstr
conjug
nlp
enhanc
immunostimulatori
abil
cpg
mpla
vitro
suggest
empti
nlp
elicit
weak
immunostimulatori
respons
next
address
whether
nlp
conjug
also
enhanc
immunostimul
cpg
mpla
vivo
nlp
cpg
nlp
mpla
nlp
free
cpg
free
mpla
inject
ip
mice
variou
dose
serum
harvest
h
later
quantifi
cytokin
level
elisa
significantli
higher
level
serum
tnfa
rant
induc
cpg
nlp
administr
compar
free
cpg
mg
dose
similarli
mpla
nlp
construct
elicit
significantli
higher
level
tnfa
rant
cytokin
level
compar
free
mpla
everi
dose
test
fig
observ
vitro
empti
nlp
elicit
low
level
cytokin
dose
depend
manner
vivo
fig
data
demonstr
conjug
nlp
enhanc
immunostimulatori
abil
cpg
mpla
vitro
vivo
character
extent
nlp
conjug
enhanc
stimul
cpg
mpla
vivo
assess
activ
cellular
level
quantifi
cell
surfac
express
protein
involv
antigen
present
costimul
macrophag
dendrit
cell
mice
inject
ip
nlp
cpg
nlp
mpla
nlp
free
cpg
free
mpla
spleen
harvest
h
postinject
splenocyt
isol
stain
cell
surfac
marker
identifi
macrophag
dendrit
cell
well
activ
marker
mhc
class
ii
iaie
surfac
macrophag
fig
surfac
dendrit
cell
fig
express
level
activ
marker
cell
type
significantli
higher
follow
inject
cpg
nlp
mpla
nlp
rel
free
agonist
fig
inflammatori
data
demonstr
agonist
nlp
construct
elicit
robust
innat
immun
respons
vivo
free
agonist
alon
administ
equival
dose
order
understand
mechan
underli
abil
nlp
augment
immunostimulatori
profil
cpg
mpla
vivo
investig
chang
gene
express
elicit
nlp
cpg
nlp
mpla
nlp
free
cpg
free
mpla
treatment
use
quantit
rtpcr
pathway
array
mous
antibacteri
respons
array
sabiosci
simultan
measur
express
gene
previous
demonstr
involv
innat
respons
bacteri
infect
use
analyz
gene
express
spleen
min
h
postip
inject
chang
gene
express
minim
min
data
shown
howev
robust
chang
level
gene
express
number
key
gene
detect
fig
h
interestingli
scatterplot
analysi
indic
number
gene
exhibit
least
regul
similar
among
nlp
cpg
nlp
mpla
nlp
group
either
cpg
nlp
mpla
nlp
correspond
free
agonist
control
fig
furthermor
magnitud
chang
consist
much
higher
among
nlp
cpg
nlp
mpla
nlp
group
either
free
cpg
mpla
level
express
gene
exhibit
least
regul
summar
fig
full
summari
chang
gene
express
gene
see
supplement
tabl
cpg
nlp
mpla
nlp
induc
much
higher
level
express
number
gene
either
cpg
mpla
alon
fig
includ
set
mani
gene
encod
cytokin
chemokin
well
sever
gene
involv
tlr
nfkb
signal
pathway
surprisingli
nlp
alon
also
induc
high
level
express
mani
gene
case
equal
almost
equal
level
induc
either
cpg
nlp
mpla
nlp
fig
supplement
tabl
inde
base
pattern
gene
express
appear
major
gene
upregul
induc
cpg
nlp
mpla
nlp
could
attribut
nlp
rather
cpg
mpla
data
suggest
nlp
immunostimulatori
dose
examin
studi
may
explain
part
abil
nlp
augment
immunostimulatori
profil
cpg
mpla
vivo
investig
chang
biodistribut
traffick
agonist
associ
nlp
conjug
use
flow
cytometri
quantifi
amount
fluorescentlylabel
cpg
nlp
cpg
spleen
follow
ip
inject
cpgquasar
nlp
free
cpgquasar
inject
mice
spleen
harvest
h
postinject
analyz
presenc
cpgquasar
fig
conjug
cpgquasar
nlp
result
signific
increas
percentag
splenocyt
quasar
posit
h
averag
versu
fig
increas
percentag
cpg
posit
splenocyt
nlp
conjug
even
dramat
later
time
point
greater
splenocyt
exhibit
quasar
fluoresc
h
postinject
label
cpg
conjug
nlp
uptak
specif
cell
type
determin
antibodi
stain
fig
uptak
macrophag
dendrit
cell
similar
time
point
signific
differ
emerg
later
time
point
fig
data
suggest
conjug
nlp
may
enhanc
traffick
cpg
spleen
retent
cpg
later
time
point
andor
uptak
cpg
per
cell
basi
combin
three
scenario
enhanc
uptak
conjug
nlp
confirm
use
purifi
splenocyt
popul
ex
vivo
splenocyt
sort
popul
incub
cpgquasar
either
free
conjug
nlp
h
analyz
flow
cytometri
nlp
conjug
result
signific
enhanc
amount
cpgquasar
taken
cell
popul
measur
mean
fluoresc
intens
quasar
signal
fig
f
experi
need
fulli
elabor
mechan
nlp
may
alter
biodistribut
retent
agonist
vivo
result
indic
conjug
nlp
enhanc
uptak
cpg
cell
worth
note
experi
perform
cpg
nlp
mpla
amen
label
fluoresc
dye
howev
hypothes
similar
trend
would
like
observ
mpla
nlp
effect
due
deliveri
via
nlp
platform
order
assess
translat
result
human
investig
abil
nlp
enhanc
stimul
cpg
mpla
primari
human
dendrit
cell
pbmc
collect
two
healthi
human
donor
incub
cpg
nlp
mpla
nlp
free
cpg
free
mpla
variou
dose
h
subsequ
analyz
quantifi
intracellular
cytokin
level
flow
cytometri
gate
scheme
defin
myeloid
plasmacytoid
dendrit
cell
mdc
pdc
respect
detail
fig
cpg
nlp
stimul
significantli
higher
frequenc
ifna
pdc
compar
free
cpg
across
titrat
rang
fig
significantli
higher
frequenc
mdc
also
observ
respons
mpla
nlp
compar
free
mpla
across
titrat
rang
fig
result
suggest
conjug
nlp
enhanc
innat
immun
respons
murin
cell
human
cell
well
indic
potenti
clinic
translat
nlp
platform
innat
immun
modul
importantli
comparison
innat
immun
respons
tlr
agonist
across
differ
speci
allow
thorough
understand
speciesspecif
sensit
tlr
stimul
proof
principl
efficaci
agonist
nlp
construct
protect
pathogen
challeng
assess
use
mous
model
influenza
cpg
nlp
select
challeng
studi
prophylact
intranas
administr
cpg
previous
shown
confer
partial
protect
mice
lethal
infect
strain
influenza
mice
treat
mg
cpg
nlp
cpg
nlp
pb
h
prior
infect
lethal
dose
weight
loss
monitor
day
postinfect
mice
receiv
cpg
nlp
prior
infect
afford
protect
surviv
challeng
day
fig
mice
treat
nlp
free
cpg
exhibit
progress
weight
loss
rate
similar
pb
treat
mice
euthan
day
postinfect
data
suggest
stimul
innat
immun
respons
cpg
nlp
provid
protect
lethal
influenza
challeng
underscor
therapeut
potenti
nlp
platform
studi
investig
stimulatori
properti
immunomodulatori
complex
compris
nanolipoprotein
particl
platform
synthet
tlr
agonist
cpg
mpla
demonstr
conjug
nlp
enhanc
stimul
agonist
vitro
vivo
measur
enhanc
cytokin
releas
chang
immunoregulatori
gene
express
increas
express
key
activ
marker
surfac
apc
also
demonstr
conjug
nlp
enhanc
uptak
cpg
splenocyt
includ
macrophag
dc
importantli
effect
nlp
conjug
specif
murin
system
nlp
also
enhanc
stimul
human
dc
cpg
mpla
strikingli
mice
treat
prophylact
cpg
nlp
complex
surviv
lethal
influenza
challeng
wherea
mice
treat
equival
amount
free
cpg
afford
protect
data
import
implic
develop
hostbas
therapeut
target
infecti
diseas
pathogen
label
highest
risk
nation
secur
public
safeti
niaid
categori
pathogen
pose
signific
challeng
viabl
therapeut
option
either
avail
optim
treat
popul
event
widespread
outbreak
deliber
releas
addit
continu
threat
emerg
new
pathogen
therapeut
exist
coronavirus
respons
respiratori
syndrom
sar
mer
newli
recombin
pathogen
strain
influenza
yet
encount
therefor
event
intent
releas
pandem
outbreak
caus
pathogen
individu
vicin
outbreak
would
risk
exposur
limit
treatment
option
innat
immun
target
therapeut
tlr
agonist
nlp
complex
describ
could
employ
prophylact
event
enabl
expos
individu
build
suffici
transient
immun
surviv
fig
conjug
tlr
agonist
nlp
enhanc
cytokin
product
human
dendrit
cell
pbmc
purifi
blood
collect
healthi
donor
stimul
h
cpg
nlp
mpla
nlp
cpg
mpla
cell
analyz
flow
cytometri
cytokin
product
gate
scheme
defin
myeloid
plasmacytoid
dendrit
cell
dendrit
cell
mdc
pdc
respect
plot
gate
success
left
right
dendrit
cell
fscint
sscint
hladr
lin
lin
cocktail
contain
antibodi
identifi
lymphocyt
monocyt
eosinophil
neutrophil
hladr
use
distinguish
dendrit
cell
basophil
mdc
pdc
distinguish
express
respect
last
two
plot
demonstr
lack
ifna
tnfa
product
mdc
pdc
respect
pb
control
sampl
b
cpg
nlp
stimul
ifna
tnfaproduc
pdc
cpg
alon
plot
repres
data
collect
one
donor
bar
graph
repres
mean
valu
cytokin
posit
cell
donor
perform
duplic
standard
deviat
error
bar
c
mpla
nlp
stimul
tnfaproduc
mdc
mpla
alon
plot
repres
data
collect
one
donor
bar
graph
repres
mean
valu
cytokin
posit
cell
donor
perform
duplic
standard
deviat
error
bar
p
p
p
student
test
may
otherwis
consid
lethal
infect
preced
target
innat
immun
prophylact
countermeasur
biothreat
agent
cpg
previous
shown
protect
mice
francisella
tularensi
burkholderia
pseudomallei
synthet
agonist
shown
protect
mice
f
tularensi
pesti
howev
protect
afford
studi
variabl
demonstr
margin
better
surviv
untreat
control
anim
studi
mice
pretreat
cpg
free
agonist
afford
level
protect
influenza
challeng
wherea
mice
receiv
cpg
nlp
complex
surviv
infect
suggest
administ
tlr
agonist
complex
particl
improv
therapeut
index
agonist
rais
intrigu
possibl
incomplet
protect
afford
earlier
studi
may
improv
upon
administr
tlr
agonistsparticul
complex
oppos
free
agonist
alon
particul
deliveri
system
mainli
form
aluminum
salt
alum
use
centuri
mechan
behind
enhanc
vaccin
immunogen
recent
begun
unravel
date
mani
vari
type
synthet
micro
nanoparticl
explor
vaccin
platform
numer
studi
document
wide
rang
effect
innat
immun
respons
extens
review
ref
recent
studi
demonstr
alum
variou
form
well
poli
lacticcoglycol
acid
microparticl
activ
inflammasom
report
differ
requir
outcom
inflammasom
activ
requir
inflammasom
activ
subsequ
induct
adapt
respons
unclear
activ
variou
aspect
innat
immun
particul
adjuv
well
establish
data
provid
evid
nanoparticlemedi
activ
innat
immun
respons
inject
anim
nlp
without
agonist
result
robust
chang
express
level
gene
encod
protein
involv
tlrnlr
signal
cytokin
chemokin
signal
well
innat
immun
pathway
fig
suggest
particl
immunostimulatori
look
activ
inflammasom
directli
gene
relat
inflammasom
activ
upregul
follow
nlp
inject
includ
fig
interestingli
anoth
recent
studi
demonstr
vitro
treatment
dc
poli
gglutam
acid
particl
induc
express
mani
gene
involv
tlr
signal
includ
mani
gene
cytokin
signal
transduct
molecul
found
express
respons
nlp
treatment
studi
thu
preced
robust
chang
express
immunostimulatori
gene
follow
nanoparticl
administr
remain
elucid
nlpinduc
chang
gene
express
relat
downstream
immun
respons
ie
product
cytokin
surfac
express
activ
marker
apc
wherea
larg
chang
gene
express
detect
spleen
follow
ip
administr
nlp
proinflammatori
cytokin
level
serum
minim
fig
increas
observ
surfac
express
activ
marker
splenic
apc
fig
moreov
chang
gene
express
induc
cpg
nlp
mpla
nlp
compar
nlp
alon
yet
high
level
serum
cytokin
robust
upregul
activ
marker
observ
follow
administr
agonist
nlp
complex
work
requir
understand
impact
nlpdepend
transcript
chang
whether
respons
short
live
translat
unknown
cellular
output
signific
physiolog
consequ
cellular
organism
level
tlr
agonist
present
nlp
data
clearli
demonstr
conjug
nlp
enhanc
innat
immun
respons
tlr
agonist
investig
necessari
elucid
mechan
respons
enhanc
one
possibl
method
enhanc
could
relat
cluster
togeth
multipl
molecul
mpla
cpg
cell
encount
one
nlp
effect
encount
molecul
mpla
molecul
cpg
fig
f
increas
local
concentr
agonist
may
result
higher
level
activ
per
cell
basi
furthermor
data
demonstr
nlp
enhanc
uptak
cpg
macrophag
dendrit
cell
fig
f
may
result
increas
activ
level
receptor
cpg
intracellular
rtpcr
analysi
immunoregulatori
gene
suggest
nlp
particl
may
innat
immun
agonist
therefor
enhanc
could
part
due
synergist
effect
simultan
deliveri
multipl
agonist
vivo
respons
agonist
nlp
construct
may
augment
enhanc
traffick
agonist
secondari
lymphoid
organ
data
demonstr
higher
percentag
splenocyt
posit
cpgquasar
upon
inject
cpgquasar
nlp
versu
cpgquasar
alon
like
due
part
enhanc
uptak
promot
nlp
conjug
howev
rule
possibl
nlp
conjug
also
enhanc
traffick
cpg
spleen
furthermor
conjug
nlp
may
result
retent
cpg
spleen
longer
period
time
interest
hypothesi
given
signific
differ
percent
total
splenocyt
macrophag
dendrit
cell
seen
h
post
inject
fig
likewis
investig
also
need
understand
mechan
cpg
nlp
complex
protect
lethal
influenza
challeng
prophylact
initi
innat
immun
mean
prevent
amelior
diseas
caus
viral
infect
postul
effect
sever
mean
includ
induct
type
interferondepend
antivir
mechan
activ
nk
cell
stimul
typeantivir
cell
respons
cpg
use
experi
b
class
therefor
like
elicit
larg
amount
ifna
thu
investig
effect
antivir
cell
nk
cell
respons
lung
key
understand
mechan
behind
cpg
nlp
mediat
protect
influenza
infect
goal
studi
demonstr
nlp
conjug
enhanc
efficaci
innat
immun
activ
tlr
agonist
demonstr
util
nlp
platform
immun
modul
strategi
transient
activ
innat
immun
respons
vivo
may
use
certain
scenario
specif
popul
recogn
approach
could
also
potenti
drive
advers
reaction
healthi
human
popul
data
demonstr
potenti
util
nlpbase
innat
immun
modul
inbr
mice
repres
heterogen
present
human
popul
specif
mous
model
captur
complex
present
human
respect
genet
background
previou
exposur
infecti
agent
well
composit
individu
microbiota
factor
would
like
result
heterogen
lymphocyt
popul
tlr
stimul
could
pleiotrop
effect
would
larg
unpredict
therefor
translat
clinic
set
would
requir
refin
systemat
optim
agonist
nlp
minim
potenti
deleteri
side
effect
studi
investig
impact
tlr
agonist
nlp
complex
innat
immun
respons
vitro
vivo
demonstr
cpg
mpla
readili
incorpor
accur
quantifi
within
nlp
platform
administr
cpg
nlp
mpla
nlp
versu
administr
free
cpg
mpla
result
signific
enhanc
multipl
hallmark
innat
immun
activ
includ
cytokin
product
surfac
express
activ
marker
transcript
chang
immunoregulatori
gene
importantli
nlp
conjug
enhanc
cytokin
product
respons
agonist
mice
also
primari
human
dendrit
cell
final
util
mous
model
influenza
demonstr
prophylact
administr
cpg
nlp
complex
provid
complet
protect
otherwis
lethal
infect
efficaci
cpg
nlp
complex
amelior
infect
coupl
observ
cpg
nlp
mpla
nlp
enhanc
innat
immun
respons
murin
system
also
within
primari
human
dendrit
cell
indic
potenti
futur
clinic
applic
nlp
platform
innat
immun
modul
